Study to Evaluate Safety and Tolerability of ACT-709478 in Healthy Subjects
Clinical trial NCT03165097 · COMPLETED
Trial details
- NCT number
- NCT03165097
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2018-11-15
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.